Theme · live manifest · live theme JSON
MedTech Long '25: Diagnostic Platforms
7 tickers · $23.67B total market cap
Group: MedTech Long
AI-enhanced sequencing and immunodiagnostic platforms are crossing cost-and-throughput tipping points just as U.S. reimbursement expands to blood-based Alzheimer's, multi-cancer and AI-radiology codes. PacBio's Revio and Illumina's NovaSeq X upgrades slash $/Gb, Quanterix's p-Tau217 wins early CMS support, and iCAD's ProFound AI Risk gains CPT traction, anchoring a demand rebound for high-complexity centralized labs despite past funding droughts.
MedTech Long '25: Diagnostic Platforms tracks 7 publicly listed stocks in this theme: ICAD, ILMN, MASS, PACB, PSNL, QDEL, QTRX. See the constituent table for details.
Thesis update: 2025-05-08
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Illumina, Inc.ILMN | 04/30/2026 (AMC) | 04/30/2026 (AMC) | -10.40% | 12.80% | 5.86% | 4.35% | $21.44B | 14.2857 |
QuidelOrtho CorporationQDEL | 05/05/2026 (AMC) | 05/05/2026 (AMC) | -18.12% | -11.76% | -50.55% | 3.83% | $776.0M | 14.2857 |
Personalis, Inc.PSNL | 05/07/2026 (AMC) | 05/07/2026 (AMC) | 0.33% | -1.48% | -33.89% | 17.73% | $625.2M | 14.2857 |
Pacific Biosciences of California, Inc.PACB | 05/07/2026 (AMC) | 05/07/2026 (AMC) | -7.07% | -17.54% | -3.51% | -18.44% | $347.3M | 14.2857 |
908 Devices Inc.MASS | 05/06/2026 (BMO) | 05/06/2026 (BMO) | 1.97% | 13.96% | 5.19% | -16.09% | $256.4M | 14.2857 |
Quanterix CorporationQTRX | 05/06/2026 (AMC) | 05/06/2026 (AMC) | -7.42% | -16.67% | -43.86% | -8.73% | $118.2M | 14.2857 |
iCAD, Inc.ICAD | 08/12/2025 (AMC) | — | 0.00% | — | 0.00% | — | $106.3M | 14.2857 |
| Average | -5.82% | -3.45% | -17.25% | -2.89% | $3.38B | 14.2857 | ||
| Median | -7.07% | -6.62% | -3.51% | -2.45% | $347.3M | 14.2857 | ||
| Std Dev | 6.64% | 13.00% | 22.73% | 12.73% | $7.37B | 0.0% | ||
| Min | -18.12% | -17.54% | -50.55% | -18.44% | $106.3M | 14.2857 | ||
| Max | 1.97% | 13.96% | 5.86% | 17.73% | $21.44B | 14.2857 | ||
| % Positive Tickers | 28.57% | 33.33% | 28.57% | 50.00% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.